 PARIS and CAMBRIDGE, Mass., Oct. 06, 2021 GLOBE NEWSWIRE -- Biophytis SA NasdaqCM: BPTS, Euronext Growth Paris: ALBPS, a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases, including severe respiratory failure in patients suffering from COVID-19, today announces it will host a virtual key opinion leader KOL event on October 6th, 2021, on its lead projects, Sarconeos BIO101 for the treatment of COVID-19 and Sarcopenia. 